Clonidine and GABA compounds in a biodegradable polymer carrier

US9968572B2 · kind B2 · utility

Assignee

• Warsaw Orthopedic, Inc.

Inventors

• Jared T. Wilsey · Memphis, US
• Danielle L. Clay · Collierville, US
• Jeffrey C. Marx · Germantown, US
• William F. McKay · Memphis, US
• Josee Roy · Memphis, US
• John M. Zanella · Cordova, US

Key dates

• Filing date: Mar 31, 2016
• Grant date: May 15, 2018
• Expiry date: Jun 10, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P29/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine and a gamma-aminobutyric acid compound at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.